AAME vs IBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

AAME

37.3
AI Score
VS
IBIO Wins

IBIO

45.7
AI Score

Investment Advisor Scores

AAME

37score
Recommendation
AVOID NEW MONEY

IBIO

46score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric AAME IBIO Winner
Forward P/E 7.391 0 Tie
PEG Ratio 2.4344 0 Tie
Revenue Growth 4.8% -100.0% AAME
Earnings Growth -59.7% 0.0% IBIO
Tradestie Score 37.3/100 45.7/100 IBIO
Profit Margin 2.9% 0.0% AAME
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY BUY IBIO

Relative Price Performance (Last 90 Days)

AAME 1M: +10.6% · 3M: -12.0% IBIO 1M: +5.4% · 3M: -41.1%

Current Technical Phase

AAME

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 52.0 · Price: $1.25

IBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.8 · Price: $0.82

Fundamentals Snapshot

Metric AAME IBIO
Market Cap — —
Forward P/E 7.4 -2.7
Trailing P/E 4.4 —
Revenue (TTM) — —
Revenue Growth 0.0% -1.0%
Gross Margin 0.1% 1.0%
Operating Margin 0.0% -301.4%
EPS 0.28 -0.32
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.